Concepedia

S. Elaine Barrie

SE

Statistics

Publications

18

Citations

1.6K

H-Index

16

Active since

1976

Affiliations

Institute of Cancer Research(Current)

Cancer Research UK

Royal Marsden NHS Foundation Trust

S. Elaine Barrie is an author at Institute of Cancer Research specializing in life sciences, enzyme inhibition, and pharmacology.

Publications per year

1976–2012

18

Publications

18

Novel Steroidal Inhibitors of Human Cytochrome P45017.alpha.-Hydroxylase-C17,20-lyase): Potential Agents for the Treatment of Prostatic Cancer

Gerard A. Potter, S. Elaine Barrie, Michael Jarman et al. · Journal of Medicinal Chemistry · 1995 · 380 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Pharmacology of novel steroidal inhibitors of cytochrome P45017 (17α-hydroxylase/C17–20 lyase)

S. Elaine Barrie, Gerard A. Potter, Phyllis M. Goddard et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1994 · 255 citations

Medicine, Medicinal Chemistry, Pharmacology +16

The 16,17-Double Bond Is Needed for Irreversible Inhibition of Human Cytochrome P450<sub>17</sub><sub>α</sub> by Abiraterone (17-(3-Pyridyl)androsta-5,16-dien-3β-ol) and Related Steroidal Inhibitors

Michael Jarman, S. Elaine Barrie, J. M. LLERA · Journal of Medicinal Chemistry · 1998 · 152 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Trans‐activation of the DNA‐damage signalling protein kinase Chk2 by T‐loop exchange

Antony W. Oliver, Angela Paul, K. Boxall et al. · The EMBO Journal · 2006 · 144 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

<i>In vitro</i> and <i>In vivo</i> Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202

Florence I. Raynaud, Steven R. Whittaker, Peter M. Fischer et al. · Clinical Cancer Research · 2005 · 131 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 18